HK1009601A1 - 1'-Aminospiro-isoquinoline-4(1H),3'-pyrrolidineù-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo - Google Patents

1'-Aminospiro-isoquinoline-4(1H),3'-pyrrolidineù-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo

Info

Publication number
HK1009601A1
HK1009601A1 HK98110467A HK98110467A HK1009601A1 HK 1009601 A1 HK1009601 A1 HK 1009601A1 HK 98110467 A HK98110467 A HK 98110467A HK 98110467 A HK98110467 A HK 98110467A HK 1009601 A1 HK1009601 A1 HK 1009601A1
Authority
HK
Hong Kong
Prior art keywords
carbon atoms
aryl
lower alkyl
alkyl
tetrones
Prior art date
Application number
HK98110467A
Other languages
English (en)
Inventor
Michael Sotirios Malamas
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of HK1009601A1 publication Critical patent/HK1009601A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HK98110467A 1990-10-12 1998-09-04 1'-Aminospiro-isoquinoline-4(1H),3'-pyrrolidineù-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo HK1009601A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/596,266 US5102886A (en) 1990-10-12 1990-10-12 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
PCT/US1991/007473 WO1992006975A1 (en) 1990-10-12 1991-10-10 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors

Publications (1)

Publication Number Publication Date
HK1009601A1 true HK1009601A1 (en) 1999-06-04

Family

ID=24386645

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110467A HK1009601A1 (en) 1990-10-12 1998-09-04 1'-Aminospiro-isoquinoline-4(1H),3'-pyrrolidineù-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo

Country Status (19)

Country Link
US (1) US5102886A (pt)
EP (1) EP0553263B1 (pt)
JP (1) JP3115598B2 (pt)
KR (1) KR100228842B1 (pt)
AT (1) ATE169300T1 (pt)
AU (1) AU645865B2 (pt)
CA (1) CA2093794C (pt)
DE (1) DE69129941T2 (pt)
DK (1) DK0553263T3 (pt)
ES (1) ES2120966T3 (pt)
FI (1) FI103045B1 (pt)
HK (1) HK1009601A1 (pt)
HU (2) HU214874B (pt)
MX (1) MX9101543A (pt)
PT (1) PT99179B (pt)
RU (1) RU2110518C1 (pt)
SG (1) SG47809A1 (pt)
TW (1) TW200484B (pt)
WO (1) WO1992006975A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47554A1 (en) * 1991-11-25 1998-04-17 American Home Prod 1'-amino-2-[(benzothiazolyl)methyl)]spiro [isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
US5189168A (en) * 1991-11-25 1993-02-23 American Home Products Corporation 1'-amino-2[(benzothiazolyl)methyl]spiro-[isoquinoline-4(1H),3'-pyrrolidine]-1,2'3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
EP1400244A1 (en) 2002-09-17 2004-03-24 Warner-Lambert Company LLC New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
CL2008001839A1 (es) 2007-06-21 2009-01-16 Incyte Holdings Corp Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
JPH0426510A (ja) * 1990-05-18 1992-01-29 Tonen Corp 炭素系粒子、その製造方法及びその用途
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors

Also Published As

Publication number Publication date
JPH06502175A (ja) 1994-03-10
WO1992006975A1 (en) 1992-04-30
FI103045B (fi) 1999-04-15
EP0553263A1 (en) 1993-08-04
HU211601A9 (en) 1995-12-28
PT99179B (pt) 1999-04-30
FI931601A0 (fi) 1993-04-08
SG47809A1 (en) 1998-04-17
PT99179A (pt) 1992-09-30
AU645865B2 (en) 1994-01-27
DE69129941D1 (de) 1998-09-10
CA2093794C (en) 2002-01-22
ES2120966T3 (es) 1998-11-16
TW200484B (pt) 1993-02-21
US5102886A (en) 1992-04-07
HU214874B (hu) 1998-07-28
HU9301042D0 (en) 1993-07-28
FI103045B1 (fi) 1999-04-15
AU8902691A (en) 1992-05-20
KR930702346A (ko) 1993-09-08
EP0553263B1 (en) 1998-08-05
RU2110518C1 (ru) 1998-05-10
ATE169300T1 (de) 1998-08-15
DE69129941T2 (de) 1999-02-18
HUT67017A (en) 1995-01-30
DK0553263T3 (da) 1999-05-10
KR100228842B1 (ko) 1999-11-01
MX9101543A (es) 1992-06-05
JP3115598B2 (ja) 2000-12-11
FI931601A (fi) 1993-04-08
CA2093794A1 (en) 1992-04-13

Similar Documents

Publication Publication Date Title
ZA924425B (en) Tetrahydropyrrolo(1,2-a)pyrazine-4-spiro-3'-pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2042113A1 (en) Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
HK1009601A1 (en) 1'-Aminospiro-isoquinoline-4(1H),3'-pyrrolidineù-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo
CA2042112A1 (en) N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
MXPA05012360A (es) Derivados de benzotiazol como ligandos receptores de adenosina.
HK1011356A1 (en) Alkylidene analogs of 1'-aminospiro-isoquinoline-4(1H),3'-pyrrolidineù-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors in vivo
SG47554A1 (en) 1'-amino-2-[(benzothiazolyl)methyl)]spiro [isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
ES8306370A1 (es) "procedimiento para la preparacion de derivados de imidazol".

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041010